• Products
  • Research
  • About
  • Contact Info

  • You are currently browsing the Oasis Diagnostics® blog archives for January, 2018.

  • Pages

    • About
    • Blog
    • Contact Us
    • Education
    • Genomics Products
    • Home
    • Home Page
    • Home Page – extra
    • How it Works
    • Immunoassay Products
    • News & Events
    • Oasis Research Lab
    • Partners
    • Products
    • Resources
    • Saliva Products
    • Sample Page
    • Sample Page
    • Support
    • Thank You
    • thankyou

  • Archives

    • September 2023
    • November 2022
    • September 2022
    • September 2021
    • September 2020
    • June 2020
    • May 2020
    • December 2019
    • September 2019
    • March 2019
    • February 2018
    • January 2018
    • July 2017
    • May 2017
    • March 2017
    • January 2017
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • May 2016
    • December 2015
    • November 2015
    • July 2015
    • June 2015
    • February 2015
    • October 2014
    • August 2014
    • July 2014
    • May 2014
    • January 2014
    • August 2013
    • May 2013
    • August 2012
    • July 2012
    • June 2012
    • November 2011
    • September 2011
    • January 2011
    • October 2010
    • June 2010
    • April 2009
    • January 2008

  • Categories

    • Black Hills (10)
    • Featured Products (9)
    • Genomics (4)
      • COVID (1)
    • Molzym (4)
    • News (37)
      • Press Releases (18)
      • Recent Events (8)
    • Operon (8)
    • Products (14)
    • Saliva (15)
    • Third Party (1)
    • Uncategorized (2)
    • Viennalab (26)

Pioneers in Oral Fluid Diagnostics

Oasis Diagnostics® Corporation was founded to conceive, develop, and commercialize high-quality tools for the non-invasive diagnosis and detection of diseases based on non-invasive specimens, particularly saliva or oral fluid. The Company’s technologies address the three main segments of the in vitro diagnostics [IVD] marketplace: molecular diagnostics [including DNA and, RNA], or nucleic acid testing [NAT], point of care [POC] testing and testing performed in the laboratory.

At Oasis Diagnostics® Corporation, we believe the ability to use non-invasive and cost effective solutions for sample collection offers up multiple advantages over more invasive technologies that utilize blood, tissue, cerebrospinal fluid and others and has set about developing a portfolio of proprietary and patented devices with multiple applications in public health, testing for drugs of abuse, general wellness and others.


Address
15720 NE 31st Avenue, Vancouver, WA 98686 USA
Phone
360-546-1563

Fax
360-546-1581
© Copyright 2025, Oasis Diagnostics® Corporation

Have Questons? Lets Connect


Send us an email by using the form below. Someone will reach out in the next 24hrs. We look forward to connecting with you.